0.024337
0.000000
0.000000
0.000000
0.024337
0.000000
0.000000
0.000000
0.009441
0.00000
0.00000
0.00000
Murray, A.J.
Head, J.G.
Barker, J.J.
Brady, R.L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
41.090
41.090
105.920
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
5
778
782
10.1038/1816
9731771
Engineering an intertwined form of CD2 for stability and assembly.
1998
10.2210/pdb1a6p/pdb
pdb_00001a6p
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
287
1
MIRRORS
IMAGE PLATE
1997-08
MARRESEARCH
MIRRORS
M
x-ray
1
1.488
1.0
PX7.2
SRS
1.488
SYNCHROTRON
SRS BEAMLINE PX7.2
10538.900
T-CELL SURFACE ANTIGEN CD2
DOMAIN 1
DEL(M46, K47)
2
man
polymer
18.015
water
81
nat
water
no
no
GTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKPFLKSGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNG
TRILDKALDLRILE
GTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKPFLKSGAFEILANGDLKIKNLTRDDSGTYNVTVYSTNG
TRILDKALDLRILE
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Norway rat
Rattus
Escherichia
sample
T-LYMPHOCYTES
10116
Rattus norvegicus
CYTOPLASM
562
Escherichia coli
MC1061
PLASMID
PGEX-2T
1
2.08
31.8
4.6
20% PEG 4000, 5% GLYCEROL, 0.1M NACO, PH 4.6
database_2
pdbx_database_status
pdbx_initial_refinement_model
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Other
Refinement description
1
0
1998-06-17
1
1
2008-03-24
1
2
2011-07-13
1
3
2023-08-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1998-02-26
REL
REL
HOH
water
1HNG
PDB ENTRY 1HNG
PDB
experimental model
HOH
3
2
HOH
HOH
100
A
HOH
4
2
HOH
HOH
101
A
HOH
5
2
HOH
HOH
102
A
HOH
8
2
HOH
HOH
103
A
HOH
11
2
HOH
HOH
104
A
HOH
12
2
HOH
HOH
105
A
HOH
15
2
HOH
HOH
106
A
HOH
16
2
HOH
HOH
107
A
HOH
18
2
HOH
HOH
108
A
HOH
19
2
HOH
HOH
109
A
HOH
21
2
HOH
HOH
110
A
HOH
22
2
HOH
HOH
111
A
HOH
26
2
HOH
HOH
112
A
HOH
34
2
HOH
HOH
113
A
HOH
35
2
HOH
HOH
114
A
HOH
36
2
HOH
HOH
115
A
HOH
38
2
HOH
HOH
116
A
HOH
49
2
HOH
HOH
117
A
HOH
57
2
HOH
HOH
118
A
HOH
59
2
HOH
HOH
119
A
HOH
61
2
HOH
HOH
120
A
HOH
62
2
HOH
HOH
121
A
HOH
71
2
HOH
HOH
122
A
HOH
72
2
HOH
HOH
123
A
HOH
82
2
HOH
HOH
124
A
HOH
89
2
HOH
HOH
125
A
HOH
92
2
HOH
HOH
126
A
HOH
96
2
HOH
HOH
127
A
HOH
106
2
HOH
HOH
128
A
HOH
202
2
HOH
HOH
129
A
HOH
203
2
HOH
HOH
130
A
HOH
206
2
HOH
HOH
131
A
HOH
207
2
HOH
HOH
132
A
HOH
210
2
HOH
HOH
133
A
HOH
211
2
HOH
HOH
134
A
HOH
214
2
HOH
HOH
135
A
HOH
217
2
HOH
HOH
136
A
HOH
218
2
HOH
HOH
137
A
HOH
219
2
HOH
HOH
138
A
HOH
220
2
HOH
HOH
139
A
HOH
221
2
HOH
HOH
140
A
HOH
222
2
HOH
HOH
141
A
HOH
223
2
HOH
HOH
142
A
HOH
224
2
HOH
HOH
143
A
HOH
225
2
HOH
HOH
144
A
HOH
226
2
HOH
HOH
145
A
HOH
227
2
HOH
HOH
146
A
HOH
228
2
HOH
HOH
147
A
HOH
232
2
HOH
HOH
148
A
HOH
236
2
HOH
HOH
149
A
HOH
237
2
HOH
HOH
150
A
HOH
238
2
HOH
HOH
151
A
HOH
246
2
HOH
HOH
152
A
HOH
248
2
HOH
HOH
153
A
HOH
1
2
HOH
HOH
100
B
HOH
2
2
HOH
HOH
101
B
HOH
7
2
HOH
HOH
102
B
HOH
9
2
HOH
HOH
103
B
HOH
10
2
HOH
HOH
104
B
HOH
14
2
HOH
HOH
105
B
HOH
27
2
HOH
HOH
106
B
HOH
29
2
HOH
HOH
107
B
HOH
32
2
HOH
HOH
108
B
HOH
47
2
HOH
HOH
109
B
HOH
52
2
HOH
HOH
110
B
HOH
55
2
HOH
HOH
111
B
HOH
58
2
HOH
HOH
112
B
HOH
63
2
HOH
HOH
113
B
HOH
77
2
HOH
HOH
114
B
HOH
112
2
HOH
HOH
115
B
HOH
113
2
HOH
HOH
116
B
HOH
120
2
HOH
HOH
117
B
HOH
216
2
HOH
HOH
118
B
HOH
229
2
HOH
HOH
119
B
HOH
233
2
HOH
HOH
120
B
HOH
235
2
HOH
HOH
121
B
HOH
239
2
HOH
HOH
122
B
HOH
240
2
HOH
HOH
123
B
HOH
241
2
HOH
HOH
124
B
HOH
242
2
HOH
HOH
125
B
HOH
244
2
HOH
HOH
126
B
GLY
4
n
1
GLY
4
A
THR
5
n
2
THR
5
A
VAL
6
n
3
VAL
6
A
TRP
7
n
4
TRP
7
A
GLY
8
n
5
GLY
8
A
ALA
9
n
6
ALA
9
A
LEU
10
n
7
LEU
10
A
GLY
11
n
8
GLY
11
A
HIS
12
n
9
HIS
12
A
GLY
13
n
10
GLY
13
A
ILE
14
n
11
ILE
14
A
ASN
15
n
12
ASN
15
A
LEU
16
n
13
LEU
16
A
ASN
17
n
14
ASN
17
A
ILE
18
n
15
ILE
18
A
PRO
19
n
16
PRO
19
A
ASN
20
n
17
ASN
20
A
PHE
21
n
18
PHE
21
A
GLN
22
n
19
GLN
22
A
MET
23
n
20
MET
23
A
THR
24
n
21
THR
24
A
ASP
25
n
22
ASP
25
A
ASP
26
n
23
ASP
26
A
ILE
27
n
24
ILE
27
A
ASP
28
n
25
ASP
28
A
GLU
29
n
26
GLU
29
A
VAL
30
n
27
VAL
30
A
ARG
31
n
28
ARG
31
A
TRP
32
n
29
TRP
32
A
GLU
33
n
30
GLU
33
A
ARG
34
n
31
ARG
34
A
GLY
35
n
32
GLY
35
A
SER
36
n
33
SER
36
A
THR
37
n
34
THR
37
A
LEU
38
n
35
LEU
38
A
VAL
39
n
36
VAL
39
A
ALA
40
n
37
ALA
40
A
GLU
41
n
38
GLU
41
A
PHE
42
n
39
PHE
42
A
LYS
43
n
40
LYS
43
A
ARG
44
n
41
ARG
44
A
LYS
45
n
42
LYS
45
A
PRO
48
n
43
PRO
48
A
PHE
49
n
44
PHE
49
A
LEU
50
n
45
LEU
50
A
LYS
51
n
46
LYS
51
A
SER
52
n
47
SER
52
A
GLY
53
n
48
GLY
53
A
ALA
54
n
49
ALA
54
A
PHE
55
n
50
PHE
55
A
GLU
56
n
51
GLU
56
A
ILE
57
n
52
ILE
57
A
LEU
58
n
53
LEU
58
A
ALA
59
n
54
ALA
59
A
ASN
60
n
55
ASN
60
A
GLY
61
n
56
GLY
61
A
ASP
62
n
57
ASP
62
A
LEU
63
n
58
LEU
63
A
LYS
64
n
59
LYS
64
A
ILE
65
n
60
ILE
65
A
LYS
66
n
61
LYS
66
A
ASN
67
n
62
ASN
67
A
LEU
68
n
63
LEU
68
A
THR
69
n
64
THR
69
A
ARG
70
n
65
ARG
70
A
ASP
71
n
66
ASP
71
A
ASP
72
n
67
ASP
72
A
SER
73
n
68
SER
73
A
GLY
74
n
69
GLY
74
A
THR
75
n
70
THR
75
A
TYR
76
n
71
TYR
76
A
ASN
77
n
72
ASN
77
A
VAL
78
n
73
VAL
78
A
THR
79
n
74
THR
79
A
VAL
80
n
75
VAL
80
A
TYR
81
n
76
TYR
81
A
SER
82
n
77
SER
82
A
THR
83
n
78
THR
83
A
ASN
84
n
79
ASN
84
A
GLY
85
n
80
GLY
85
A
THR
86
n
81
THR
86
A
ARG
87
n
82
ARG
87
A
ILE
88
n
83
ILE
88
A
LEU
89
n
84
LEU
89
A
ASP
90
n
85
ASP
90
A
LYS
91
n
86
LYS
91
A
ALA
92
n
87
ALA
92
A
LEU
93
n
88
LEU
93
A
ASP
94
n
89
ASP
94
A
LEU
95
n
90
LEU
95
A
ARG
96
n
91
ARG
96
A
ILE
97
n
92
ILE
97
A
LEU
98
n
93
LEU
98
A
GLU
99
n
94
GLU
99
A
GLY
4
n
1
GLY
4
B
THR
5
n
2
THR
5
B
VAL
6
n
3
VAL
6
B
TRP
7
n
4
TRP
7
B
GLY
8
n
5
GLY
8
B
ALA
9
n
6
ALA
9
B
LEU
10
n
7
LEU
10
B
GLY
11
n
8
GLY
11
B
HIS
12
n
9
HIS
12
B
GLY
13
n
10
GLY
13
B
ILE
14
n
11
ILE
14
B
ASN
15
n
12
ASN
15
B
LEU
16
n
13
LEU
16
B
ASN
17
n
14
ASN
17
B
ILE
18
n
15
ILE
18
B
PRO
19
n
16
PRO
19
B
ASN
20
n
17
ASN
20
B
PHE
21
n
18
PHE
21
B
GLN
22
n
19
GLN
22
B
MET
23
n
20
MET
23
B
THR
24
n
21
THR
24
B
ASP
25
n
22
ASP
25
B
ASP
26
n
23
ASP
26
B
ILE
27
n
24
ILE
27
B
ASP
28
n
25
ASP
28
B
GLU
29
n
26
GLU
29
B
VAL
30
n
27
VAL
30
B
ARG
31
n
28
ARG
31
B
TRP
32
n
29
TRP
32
B
GLU
33
n
30
GLU
33
B
ARG
34
n
31
ARG
34
B
GLY
35
n
32
GLY
35
B
SER
36
n
33
SER
36
B
THR
37
n
34
THR
37
B
LEU
38
n
35
LEU
38
B
VAL
39
n
36
VAL
39
B
ALA
40
n
37
ALA
40
B
GLU
41
n
38
GLU
41
B
PHE
42
n
39
PHE
42
B
LYS
43
n
40
LYS
43
B
ARG
44
n
41
ARG
44
B
LYS
45
n
42
LYS
45
B
PRO
48
n
43
PRO
48
B
PHE
49
n
44
PHE
49
B
LEU
50
n
45
LEU
50
B
LYS
51
n
46
LYS
51
B
SER
52
n
47
SER
52
B
GLY
53
n
48
GLY
53
B
ALA
54
n
49
ALA
54
B
PHE
55
n
50
PHE
55
B
GLU
56
n
51
GLU
56
B
ILE
57
n
52
ILE
57
B
LEU
58
n
53
LEU
58
B
ALA
59
n
54
ALA
59
B
ASN
60
n
55
ASN
60
B
GLY
61
n
56
GLY
61
B
ASP
62
n
57
ASP
62
B
LEU
63
n
58
LEU
63
B
LYS
64
n
59
LYS
64
B
ILE
65
n
60
ILE
65
B
LYS
66
n
61
LYS
66
B
ASN
67
n
62
ASN
67
B
LEU
68
n
63
LEU
68
B
THR
69
n
64
THR
69
B
ARG
70
n
65
ARG
70
B
ASP
71
n
66
ASP
71
B
ASP
72
n
67
ASP
72
B
SER
73
n
68
SER
73
B
GLY
74
n
69
GLY
74
B
THR
75
n
70
THR
75
B
TYR
76
n
71
TYR
76
B
ASN
77
n
72
ASN
77
B
VAL
78
n
73
VAL
78
B
THR
79
n
74
THR
79
B
VAL
80
n
75
VAL
80
B
TYR
81
n
76
TYR
81
B
SER
82
n
77
SER
82
B
THR
83
n
78
THR
83
B
ASN
84
n
79
ASN
84
B
GLY
85
n
80
GLY
85
B
THR
86
n
81
THR
86
B
ARG
87
n
82
ARG
87
B
ILE
88
n
83
ILE
88
B
LEU
89
n
84
LEU
89
B
ASP
90
n
85
ASP
90
B
LYS
91
n
86
LYS
91
B
ALA
92
n
87
ALA
92
B
LEU
93
n
88
LEU
93
B
ASP
94
n
89
ASP
94
B
LEU
95
n
90
LEU
95
B
ARG
96
n
91
ARG
96
B
ILE
97
n
92
ILE
97
B
LEU
98
n
93
LEU
98
B
GLU
99
n
94
GLU
99
B
author_and_software_defined_assembly
PISA
2
dimeric
7390
-38
10560
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
VAL
6
A
O
VAL
3
B
N
ASP
94
B
N
ASP
89
B
O
ILE
88
B
O
ILE
83
B
N
VAL
80
B
N
VAL
75
B
O
ASN
77
B
O
ASN
72
A
N
GLU
33
A
N
GLU
30
A
O
VAL
30
A
O
VAL
27
A
N
PHE
42
A
N
PHE
39
A
O
ILE
14
A
O
ILE
11
B
N
ILE
65
B
N
ILE
60
B
O
LYS
64
B
O
LYS
59
B
N
GLU
56
B
N
GLU
51
A
O
GLU
56
A
O
GLU
51
A
N
LYS
64
A
N
LYS
59
A
O
LEU
63
A
O
LEU
58
B
N
LEU
16
B
N
LEU
13
B
O
VAL
6
B
O
VAL
3
A
N
ASP
94
A
N
ASP
89
A
O
ILE
88
A
O
ILE
83
A
N
VAL
80
A
N
VAL
75
A
O
ASN
77
A
O
ASN
72
B
N
GLU
33
B
N
GLU
30
B
O
VAL
30
B
O
VAL
27
B
N
PHE
42
B
N
PHE
39
1
A
A
CD
OE2
GLU
GLU
99
99
0.074
0.011
1.252
1.326
N
1
B
B
CD
OE2
GLU
GLU
99
99
0.071
0.011
1.252
1.323
N
1
A
ASN
20
39.43
72.64
1
A
ASP
26
-92.47
30.96
1
B
ASN
20
37.43
80.88
PARHCSDX.PRO
TOPHCSDX.PRO
32.46
RESIDUES 20 - 29 IN BOTH CHAINS COMPRISE A FLEXIBLE LOOP
REGION; HENCE THE B FACTORS ARE HIGH WITH POOR PACKING, AND
SOME NON H-BOND DONORS IN THE AREA.
0.2960000
0.2186000
0.2186000
2.08
15.
10520
10589
10.
99.1
RANDOM
2.08
10.
1
THROUGHOUT
0.
MOLECULAR REPLACEMENT
PDB ENTRY 1HNG
2.08
15.
88
1572
0
0
1484
0.006
1.291
0.3793000
0.027
0.3005000
2.17
116
1070
8
10.5
99.1
24.34
2.0
15.
1A6P
10589
0.
0.0590000
0.0590000
1
16.1
2.89
99.1
0.2950000
2.08
2.15
2.57
0.2950000
99.
model building
X-PLOR
3.851
refinement
X-PLOR
3.851
data reduction
DENZO
data scaling
SCALEPACK
phasing
X-PLOR
3.851
ENGINEERING OF A MISFOLDED FORM OF CD2
1
N
N
1
N
N
2
N
N
2
N
N
A
ARG
70
A
ARG
65
HELX_P
A
ASP
72
A
ASP
67
5
1
3
B
ARG
70
B
ARG
65
HELX_P
B
ASP
72
B
ASP
67
5
2
3
CELL ADHESION
DOMAIN SWAPPING, HINGE LOOP, OLIGOMER EVOLUTION, T LYMPHOCYTE ADHESION GLYCOPROTEIN, CELL ADHESION
CD2_RAT
UNP
1
1
P08921
MRCKFLGSFFLLFSLSSKGADCRDSGTVWGALGHGINLNIPNFQMTDDIDEVRWERGSTLVAEFKRKMKPFLKSGAFEIL
ANGDLKIKNLTRDDSGTYNVTVYSTNGTRILDKALDLRILEMVSKPMIYWECSNATLTCEVLEGTDVELKLYQGKEHLRS
LRQKTMSYQWTNLRAPFKCKAVNRVSQESEMEVVNCPEKGLPLYLIVGVSAGGLLLVFFGALFIFCICKRKKRNRRRKGE
ELEIKASRMSTVERGPKPHSTQASAPASQNPVASQAPPPPGHHLQTPGHRPLPPSHRNREHQPKKRPPPSGTQVHQQKGP
PLPRPRVQPKPPCGSGDVSLPPPN
26
121
1A6P
4
99
P08921
A
1
1
94
26
121
1A6P
4
99
P08921
B
1
1
94
1
MET
deletion
1A6P
A
P08921
UNP
68
1
LYS
deletion
1A6P
A
P08921
UNP
69
2
MET
deletion
1A6P
B
P08921
UNP
68
2
LYS
deletion
1A6P
B
P08921
UNP
69
5
3
3
5
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
A
THR
5
A
THR
2
A
ALA
9
A
ALA
6
B
ARG
87
B
ARG
82
B
LEU
98
B
LEU
93
B
GLY
74
B
GLY
69
B
SER
82
B
SER
77
A
ILE
27
A
ILE
24
A
ARG
34
A
ARG
31
A
THR
37
A
THR
34
A
LYS
43
A
LYS
40
A
ILE
14
A
ILE
11
A
LEU
16
A
LEU
13
B
LEU
63
B
LEU
58
B
ILE
65
B
ILE
60
B
PHE
55
B
PHE
50
B
ILE
57
B
ILE
52
A
PHE
55
A
PHE
50
A
ILE
57
A
ILE
52
A
LEU
63
A
LEU
58
A
ILE
65
A
ILE
60
B
ILE
14
B
ILE
11
B
LEU
16
B
LEU
13
B
THR
5
B
THR
2
B
ALA
9
B
ALA
6
A
ARG
87
A
ARG
82
A
LEU
98
A
LEU
93
A
GLY
74
A
GLY
69
A
SER
82
A
SER
77
B
ILE
27
B
ILE
24
B
ARG
34
B
ARG
31
B
THR
37
B
THR
34
B
LYS
43
B
LYS
40
78
P 43